Beijing Union Pharmaceutical

Beijing Union Pharmaceutical, officially known as Beijing Union Pharmaceutical Factory LTD (BUPF), is a prominent state-owned pharmaceutical enterprise in China. Founded in 1958 and affiliated with the Institute of Materia Medica (IMM) of the Chinese Academy of Medical Sciences (CAMS), the company specializes in the industrialization of original Chinese drug research. Its portfolio is led by Bicyclol (Besano), an original Class 1 drug for liver diseases, and the antiviral drug Azvudine, which it produces for the treatment of COVID-19 and HIV. The company operates high-tech, GMP-certified manufacturing facilities in Beijing and Cangzhou, focusing on hepatology, oncology, cardiovascular health, and infectious diseases.